The FDA has granted Orphan Drug designation to BA-102 for the treatment of Phelan-McDermid syndrome, a rare neurodevelopmental disorder.

The CDC’s new data, collected from 16 U.S. locations, shows that among 8-year-olds, autism spectrum disorder (ASD) was ...